Form 4: Director Amy Wendell Converts RSUs to Solventum Stock
Insider Transaction Report
Solventum Corp. Director Amy Wendell converted 1,980 fully vested Restricted Stock Units into common stock, increasing her direct holdings.
Summary
- Amy McBride Wendell, a Director of Solventum Corp. (SOLV), acquired 1,980 shares of common stock.
- This acquisition resulted from the conversion of 1,980 fully vested Restricted Stock Units (RSUs).
- The transaction occurred on March 27, 2026, with a conversion price of $0 for the RSUs.
- Following this transaction, Ms. Wendell directly owns 7,019 shares of Solventum Corp. common stock.
- A Limited Power of Attorney, executed on March 6, 2026, authorizes Megan Bombick and Kristen Brown to file Section 16 reports on behalf of Ms. Wendell.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral event, reflecting a routine compensation settlement for a director. It indicates continued director ownership but does not signal new strategic developments or financial performance.
Positives
- Director Amy Wendell increased her direct ownership of Solventum Corp. common stock by 1,980 shares.
- The conversion of Restricted Stock Units (RSUs) indicates the vesting and settlement of previously granted equity compensation.
Future Outlook
This filing is a disclosure of a past insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
StockSavvy.ai notes that insider transactions, particularly conversions of equity awards, are common and generally reflect the settlement of compensation rather than a direct market purchase or sale based on new information. For Solventum, a recent spin-off, such transactions are part of establishing initial equity holdings for its directors.
Comparison to Industry Standards
- This transaction is a standard conversion of vested Restricted Stock Units (RSUs) into common stock, a common practice for executive and director compensation across industries.
- For example, similar RSU conversions are routinely reported by directors at companies like Johnson & Johnson (JNJ) or Medtronic (MDT) in the healthcare sector, where equity compensation is a key component of executive pay.
- The $0 acquisition price is typical for RSU settlements, as the value was granted at an earlier date.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Amy Wendell granted a Limited Power of Attorney to Megan Bombick and Kristen Brown to handle her Section 16 reporting obligations for Solventum Corporation securities. | 03/06/2026 | Streamlines compliance with SEC reporting requirements for the director, ensuring timely and accurate filings. |
Stakeholder Impact
- Shareholders: Increased direct ownership by a director may be viewed positively as it aligns her interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/06/2026 | Limited Power of Attorney executed by Amy Wendell. |
| 03/27/2026 | Transaction date for RSU conversion and common stock acquisition. |
| 03/30/2026 | Date Form 4 was signed by attorney-in-fact. |
| 05/13/2034 | Expiration date of the derivative security (RSUs) if not exercised/converted. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the conversion of vested Restricted Stock Units into common stock by a director. Such transactions are standard for equity compensation and do not typically signal new fundamental information about the company's operational performance or strategic direction. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Solventum Corp, SOLV, Amy Wendell, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Equity Compensation, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.